Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle-Reference-Cited by-同舟云学术

Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle

Published:2023-08-26 Issue: Volume: Page:
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:

Author:

Wang Zhigang¹^ORCID,Dreesen Erwin¹^ORCID

Affiliation:

1. Department of Pharmaceutical and Pharmacological Sciences, KU Leuven From the , Leuven , Belgium

Funder

Research Foundation—Flanders, Belgium

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Link

https://academic.oup.com/ibdjournal/advance-article-pdf/doi/10.1093/ibd/izad152/51271440/izad152.pdf

Reference13 articles.

1. Effect of therapeutic drug monitoring vs standard therapy during maintenance infliximab therapy on disease control in patients with immune-mediated inflammatory diseases: a randomized clinical trial;Syversen;JAMA.,2021

2. Clinical validation of a capillary blood home-sampling technique for monitoring of infliximab, vedolizumab, and C-reactive protein concentrations in patients with inflammatory bowel disease;Otten;Inflamm Bowel Dis.,2023

3. P793 Infliximab and prevention of colectomy in acute severe ulcerative colitis: an individual patient data meta-analysis;Wang;J Crohns Colitis,2023

4. Trough concentrations of infliximab guide dosing for patients with inflammatory bowel disease;Vande Casteele;Gastroenterology.,2015

5. Increasing infliximab dose based on symptoms, biomarkers, and serum drug concentrations does not increase clinical, endoscopic, and corticosteroid-free remission in patients with active luminal Crohn’s disease;D’Haens;Gastroenterology.,2018

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-throughput, low-cost quantification of 11 therapeutic antibodies using caprylic acid precipitation and LC-MS/MS;Analytica Chimica Acta;2024-07

2. Therapeutic drug monitoring of monoclonal antibodies in chronic inflammatory diseases: A snapshot of laboratories and applications across Europe;Basic & Clinical Pharmacology & Toxicology;2024-01-26

3. The Future of Therapeutic Drug Monitoring in Inflammatory Bowel Disease: An Emphasis on the Essential Ingredients;Inflammatory Bowel Diseases;2023-07-31